Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AK3.DE
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 50.32 3.25 2.16
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 2.31 11.66 11.40
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 5.24 30.56 29.04
Cash 102.26 11.04 5.46
Capex -35.49 -1.15 -0.85
Free Cash Flow -27.16 1.17 1.61
Revenue 3.56 6.51 6.29
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -0.76 0.60 0.60
Operating Margin -9.04 0.17 0.19
ROA 8.45 0.02 0.02
ROE 7.98 0.04 0.04
ROIC 1.55 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AK3.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AK3.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AK3.DE is permitted for members.